investor presentation, page-7

For those interested in factual advice from the company they only need to actually read from todaysa announced Investor Presentation. Here it is, copied straight from the presentation in terms of News Flow of actions completed and pending. We all know why Nasdaq not mentioned as this has been explained on other threads. Todays announcement updates the previous presentation and removes the un-necessary clutter of the program for the placement and share purchase plan which has been successfully done and dusted. Here is the material on NEWS FLOW:

"Newsflow
? Phase IIb randomized phase Feb 2011 (complete)
? Regulatory agreement on phase III completed
Scientific Advice with European Union (complete)
? Potency assay expected to be qualified Q2-Q3
2011(complete)
? European license for Manufacturing Q2-Q3 2011
? Phase III study recruitment commencement Q3 2011
? FDA meeting for registration study review Q3 2011
? Update Cripto 1 progress Q3-Q4 2011
? Oral HPV vaccine progress update Q3-Q4 2011
? Dubai sales in pilot commercialisation program"

As can be seen from the above the first three items scheduled for 2011 have been completed. There are another six very important items pending for this year(excluding Nasdaq) providing IMO the dynamics for continued shareholder interest and share price movement. The European license for manufacturing is likely to be first cab off the rank and I await that with optimism and enthusiasm. Hope the above removes any speculation about News Flow to come in the remainder of the year.

cheers